Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Select Healthcare Corporation Reports Impressive Q4 Results and Approves 108 Billion Buyback Program

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Healthcare cloud based
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Select Healthcare Corporation just released its impressive Q4 results, exceeding expectations and approving a buyback program of up to $1.08 billion. The company saw a 1.4% increase in revenue for the fourth quarter ending on December 31, 2022, reaching $1,581.5 million compared to the previous year.

During the last quarter of 2022, Select Healthcare did not repurchase any shares under the program. However, since the program’s inception, the company has bought back 48,234,823 shares at a cost of around $600.3 million as of December 31, 2022.

Looking ahead to the full year of 2023, Select Healthcare anticipates revenue to fall between $6.5 billion and $6.7 billion. The company also declared a cash dividend and plans to discuss its business outlook for Adjusted EBITDA and earnings per common share in an upcoming conference call.

Overall, Select Healthcare Corporation’s strong Q4 results and the approval of a substantial share repurchase program have positively impacted its stock value.

SEM Stock Shows Strong Performance with 7.75% Rise on February 23, 2024

On February 23, 2024, SEM stock showed strong performance as it traded in the middle of its 52-week range and above its 200-day simple moving average. SEM shares experienced a significant price increase of $2.01, representing a 7.75% rise from the previous market close. The stock opened at $27.66, which was $1.71 higher than its previous close, indicating a positive start to the trading day. This strong opening price momentum set the tone for the rest of the day, as SEM shares continued to climb throughout the trading session. Investors may have been encouraged by SEM’s solid performance and positive price momentum on February 23. The stock’s ability to trade above its 200-day simple moving average suggests that it may have the potential for further upside in the future. Overall, SEM’s stock performance on February 23, 2024, was impressive, with strong price momentum and a notable increase in share price. Investors will likely continue to monitor SEM closely to see if this positive trend can be sustained.

SEM Stock Performance on February 23, 2024: Total Revenue Flat, Net Income Declines

On February 23, 2024, SEM stock experienced a mixed performance based on the financial data provided by CNN Money. The total revenue for the company stood at $6.33 billion for the past year, with a quarterly total revenue of $1.67 billion. It is noteworthy that the total revenue has remained flat compared to the previous year and the previous quarter.

However, the net income for SEM tells a different story. The company reported a net income of $153.38 million for the past year, with a quarterly net income of $46.46 million. This represents a significant decrease of 60.55% in net income compared to the previous year, and a decrease of 38.35% compared to the previous quarter.

Similarly, the earnings per share (EPS) for SEM also saw a decline. The EPS was reported at $1.23 for the past year and $0.38 for the previous quarter. This indicates a decrease of 58.77% in EPS compared to the previous year and a decrease of 38.73% compared to the previous quarter.

Overall, the financial performance of SEM on February 23, 2024, shows a mixed picture. While the total revenue remained flat, the net income and EPS experienced significant declines. Investors and stakeholders will likely closely monitor the company’s future performance to assess its growth prospects and financial stability.

Tags: SEM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining Stock Market Today

AngloGold Ashanti Reports Strong Financial Results and New Gold Discovery in FY23

Electric Utilities Stock Exchange

TransAlta Reports Strong Q4 Earnings and Launches Share Buyback Program

Retail Stock Bull Market

Investors Show Confidence in Abercrombie Fitch NYSE ANF Through Options Trading

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com